Comments: NJ S301 | 2022-2023 | Regular Session

Bill Title: Provides that purchase of insulin is not subject to deductible and requires health insurers to limit copayments and coinsurance for insulin.

Spectrum: Partisan Bill (Democrat 8-0)

Status: (Introduced - Dead) 2022-01-11 - Introduced in the Senate, Referred to Senate Commerce Committee [S301 Detail]

Text: Latest bill text (Introduced) [HTML]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2022 New Jersey S301 at this time.

Social Comments on NJ S301

feedback